Cell Reports (Jul 2021)

Prostaglandin E2 amplifies IL-17 production by γδ T cells during barrier inflammation

  • Barbara Polese,
  • Bavanitha Thurairajah,
  • Hualin Zhang,
  • Cindy Leung Soo,
  • Clara A. McMahon,
  • Ghislaine Fontes,
  • Sabah N.A. Hussain,
  • Valerie Abadie,
  • Irah L. King

Journal volume & issue
Vol. 36, no. 4
p. 109456

Abstract

Read online

Summary: Interleukin-17 (IL-17)-producing γδ (γδ17) T cells are innate-like lymphocytes that contribute to protective anti-microbial responses but are also implicated in pathogenic inflammation at barrier sites. Understanding tissue-specific signals that regulate this subset is important to boost host defense mechanisms, but also to mitigate immunopathology. Here, we demonstrate that prostaglandin E2 (PGE2), a cyclooxygenase-dependent member of the eicosanoid family, directly enhances cytokine production by circulating and tissue-specific γδ17 T cells in vitro. Gain- and loss-of-function in vivo approaches further reveal that although provision of PGE2 amplifies psoriasiform inflammation, ablation of host mPGES1-dependent PGE2 synthesis is dispensable for cutaneous γδ17 T cell activation. By contrast, loss of endogenous PGE2 production or depletion of the gut microbiota compromises intestinal γδ17 T cell responses and increases disease severity during experimental colitis. Together, our results demonstrate how a lipid mediator can synergize with tissue-specific signals to enhance innate lymphocyte production of IL-17 during barrier inflammation.

Keywords